X-Ray by Scaleflow

When in the deal process should we run an X-Ray?

Pre-term-sheet for deal confidence in competitive processes. In-DD to replace or sharpen your traditional product, tech & AI DD step. Post-investment to keep a signal on the portfolio. The X-Ray fits every stage. 1 business day, 30 minutes from the target, non-intrusive.

How does the X-Ray assess AI claims specifically?

We verify what's behind the AI: the model, the data, the orchestration, the evals, the production footprint. You learn whether the AI is a genuine moat, an enabler, or theater, and what the blast radius looks like if something goes wrong. Essential under the EU AI Act, and for any AI-led thesis.

Does the target company know it's happening?

Yes. The target grants us read-only access to their repositories. That's it. Total time commitment from them is under 30 minutes.

How long does it take?

1 business day from access. Setup is under 10 minutes. We deliver two verdicts: one for your deal team, one for the company.

Do you offer ongoing monitoring across our portfolio?

Yes. The X-Ray runs quarterly or annually across portfolio companies to surface drift: architecture, velocity, tech debt, key-person risk, AI posture. You see trends over time and which portcos are on track, before you read about it in a board deck.

Can you benchmark a target against the market?

Yes. Every X-Ray score is compared against our anonymized database of 250+ assessments. We benchmark by industry vertical, company stage (Seed to Series C+), team size, revenue model, and tech stack type. For funds with multiple X-Rays, we also surface patterns across your portfolio: which targets are outliers, which are typical, and where the risk clusters.